Insider Transactions in Q4 2025 at Spruce Biosciences, Inc. (SPRB)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2025
|
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,690
+19.79%
|
$18,760
$4.53 P/Share
|
|
Dec 15
2025
|
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,360
-4.63%
|
$108,800
$80.67 P/Share
|
|
Dec 15
2025
|
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,676
+8.35%
|
-
|
|
Dec 15
2025
|
Samir M. Gharib PRESIDENT AND CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
362
-2.19%
|
$28,960
$80.67 P/Share
|
|
Dec 15
2025
|
Samir M. Gharib PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,009
+5.74%
|
-
|
|
Dec 11
2025
|
Samir M. Gharib PRESIDENT AND CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-8.2%
|
$59,840
$88.41 P/Share
|
|
Dec 11
2025
|
Samir M. Gharib PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+18.63%
|
-
|
|
Dec 11
2025
|
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,194
-14.44%
|
$193,072
$88.41 P/Share
|
|
Dec 11
2025
|
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,950
+24.58%
|
-
|
|
Dec 10
2025
|
Samir M. Gharib PRESIDENT AND CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-2.8%
|
$15,640
$85.67 P/Share
|
|
Dec 10
2025
|
Samir M. Gharib PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
514
+7.25%
|
-
|
|
Dec 10
2025
|
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
428
-4.01%
|
$36,380
$85.67 P/Share
|
|
Dec 10
2025
|
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,196
+10.08%
|
-
|
|
Oct 20
2025
|
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,539
-13.97%
|
$227,772
$148.16 P/Share
|
|
Oct 20
2025
|
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,784
+30.28%
|
-
|
|
Oct 20
2025
|
Samir M. Gharib PRESIDENT AND CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
661
-9.83%
|
$97,828
$148.16 P/Share
|
|
Oct 20
2025
|
Samir M. Gharib PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,053
+23.38%
|
-
|
|
Oct 06
2025
|
Parkman Healthcare Partners LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
514
-10.04%
|
$9,252
$18.4 P/Share
|
|
Oct 06
2025
|
Parkman Healthcare Partners LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
512
+16.38%
|
$8,704
$17.91 P/Share
|